THE INDUSTRY’S LARGEST MARKETPLACE FOR PHARMACEUTICALS
steroidify.xyz has been in operation for almost 30 years, acquiring 50’s of thousands of satisfied customers.
steroidify.xyz works very hard to establish trust with our customer. Our high-quality products and professional staff is testament to the legitimacy of our business practice.
Each brand is hand-selected and goes through a very thorough review process.
Quality is held in a very high regard at steroidify.xyz. To further legitimize these products, we do have a comprehensive
Featured
CEC 1000
MANUFACTURER Basel WAREHOUSE International Warehouse 2 ACTIVE INGREDIENT Cefaclor Key Benefits of CEC 1000 mg Eff..
Watermed
MANUFACTURER Deus Medical WAREHOUSE EU Warehouse 2 SUBSTANCE Bacteriostatic Water Introducing WATERMED, your go-to solution for Bacteriostati..
Cypo-Testosterone 250 HP
ACTIVE HALF-LIFE 7-8 Days CLASSIFICATION Anabolic Steroid DOSAGE Men: 300-1500 mg/week ACNE Yes WATER RETENTIO..
Thymosin Beta 4 (TB-500) 10mg
CLASSIFICATION Multifaceted Peptide ACNE No WATER RETENTION No HBR No HEPATOTOXICITY No ..
Ultima-GHRP-6 5mg
ACTIVE HALF-LIFE 1.5 hours PRODUCT CLASSIFICATION Peptide Hormone RECOMMENDED DOSAGE 25-50 mcg per day ACNE R..
Leukeran 2
MANUFACTURER GSK (GlaxoSmithKline) WAREHOUSE International Warehouse 2 ACTIVE INGREDIENT Chlorambucil..
Anavar 10
ACTIVE HALF-LIFE 9 Hours CLASSIFICATION Anabolic Steroid DOSAGE Men: 30-50 mg/day ACNE Rarely occurs WATER RET..
Rhogam Anti-D
ACNE No concerns here! WATER RETENTION None detected. HBR Not applicable. HEPATOTOXICITY Absolutely not! ..
Xarelto 20
ACNE No WATER RETENTION No HBR No HEPATOTOXICITY No AROMATIZATION No MANUFACTURER Bayer ..
Ultima-MOTS-C 10 mg
MANUFACTURER Ultima Pharmaceuticals - United States WAREHOUSE USA Warehouse 5 SUBSTANCE 12S rRNA-c and MT-RNR1..
Etho-Primobolan 100
ACTIVE HALF-LIFE 5-7 Days CLASSIFICATION Anabolic Steroid DOSAGE 300-800 mg/week ACNE Yes WATER ..
Ultima-Tren Hexa 100
ACTIVE HALF-LIFE 14 days CLASSIFICATION Anabolic Steroid DOSAGE 200-600 mg/week ACNE Rarely WATER..












